An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability profile including the
dose limiting toxicity of AbGn-7 in patients with chemo-refractory advanced solid tumor of
epithelial origin, and of AbGn-7 in combination with FOLFOX7 in patients with
chemo-naive/chemo-refractory recurrent, locally advanced or metastatic gastric cancer.